Synta (SNTA) Completes Additional 1.05M Common Sale

Synta Pharmaceuticals Corp. (Nasdaq: SNTA) has completed the sale of 1,050,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters of its previously announced public offering. After underwriting discounts and commissions and estimated offering expenses payable by Synta, aggr

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Oruka Therapeutics (ORKA) files $1B mixed shelf
• Noodles & Company (NDLS) files $100M mixed shelf